← Back to search

National Institutes of Health · Department of Health and Human Services

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Opening soon

Key facts

Deadline
The funder's estimated date (Oct 5, 2026) has passed. Check the official notice Estimate, not confirmed by the funder ?
Award size
Not stated: see the official notice
Match ?
Not required · Work out your budget and match
Who can apply
Larger business, City or town government, Tribal government, Private college or university, Tribal organization, Special district (utility, fire, etc.), Small business, Nonprofit with 501(c)(3), Nonprofit without 501(c)(3), County government, School district, Public college or university, State government, and others named in the official notice
Where
Anywhere in the U.S., including Tennessee

Opening soon: the funder has announced this grant, but you can't apply yet. Use the time to get ready and check whether it fits.

Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Get-ready checklist

How this fits you

  • Available in Tennessee (nationwide program)
  • No match required
  • Past Tennessee awards on file: 84

Tell us who you are to see whether you're eligible.

View on Grants.gov

More from National Institutes of Health

About this grant

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) and the underlying biological mechanisms that play a role in these cancers to inform prevention and control strategies. The proposed research is expected to advance the understanding of the unexplained rise of cancers in young adults. More specifically, studies should address one or more of the following: i) what modifiable exposures are driving the increase in the incidence of non-hereditary EOCs, and how do these factors vary by patient demographics? (ii) what biological mechanisms and host responses underly the increase in EOCs? and (iii) how can those at increased risk for developing EOCs be identified more effectively? This NOFO consolidates exploratory/developmental and research project funding mechanisms to streamline the application process and sustain momentum in this critical research area. Applicants have the option of submitting either an exploratory/developmental research project with a project period of up to 2 years or a research project with a project period of 4 to 5 years.

Who can apply, from the official notice

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Ask a partner for a letter

Who in Tennessee has won this program

37 awards to Tennessee groups in 3 counties since 1981. Largest shown:

Past Tennessee winners
Past winnerWhereAmountFiscal year
St Jude Children's Research Hospital IncMemphis, Shelby County$31.4M2003
Vanderbilt University Medical CenterNashville, Davidson County$25.8M2009
Vanderbilt University Medical CenterNashville, Davidson County$14M2016
Vanderbilt UniversityNashville, Davidson County$14M1997
Baptist Memorial Hospital-TiptonCovington, Tipton County$11.9M2014
St Jude Children's Research Hospital IncMemphis, Shelby County$11.4M2017
Vanderbilt University Medical CenterNashville, Davidson County$11.1M1981
Vanderbilt UniversityNashville, Davidson County$10.8M2020
Vanderbilt University Medical CenterNashville, Davidson County$9.8M2023
Vanderbilt University Medical CenterNashville, Davidson County$9.4M2017
St Jude Children's Research Hospital IncMemphis, Shelby County$9.2M2018
Vanderbilt University Medical CenterNashville, Davidson County$8.6M2021

Source: USAspending.gov. Past awards show who this program funds. They don't guarantee future awards.

Tennessee groups that got this money through a state agency or another organization

This federal money also reaches local groups as pass-through grants. 47 pass-through grants on file. Largest shown:

Tennessee pass-through grant winners
Past winnerWhereThroughAmountFiscal year
Vanderbilt University Medical CenterNashville, Davidson CountyHealth Research, Inc.$1.3M2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyOhio State University, the$1M2023
St Jude Children's Research Hospital IncMemphis, Shelby CountyWashington University, the$1M2024
Vanderbilt University Medical CenterNashville, Davidson CountyVanderbilt University$1M2026
Vanderbilt UniversityNashville, Davidson CountyTrustees of Dartmouth College$780K2023
Vanderbilt University Medical CenterNashville, Davidson CountyVanderbilt University$732K2024
Vanderbilt University Medical CenterNashville, Davidson CountyVanderbilt University$729K2023
St Jude Children's Research Hospital IncMemphis, Shelby CountyThe General Hospital Corporation$663K2023
Vanderbilt University Medical CenterNashville, Davidson CountyOhio State University, the$568K2024
St Jude Children's Research Hospital IncMemphis, Shelby CountyThe Regents of the University of Colorado$533K2023
Vanderbilt University Medical CenterNashville, Davidson CountyUniversity of Texas Health Science Center at Houston$519K2024
St Jude Children's Research Hospital IncMemphis, Shelby CountyBaylor College of Medicine$507K2026

Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).

About the federal program

Cancer Cause and Prevention Research
Program number 93.393 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; 2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...

Match

None required (federal program listing).

This program on SAM.gov

About the federal program

Cancer Biology Research
Program number 93.396 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following will be considered in making funding decisions: 1) Scientific and technical merit of the proposed project as determined by scientific peer review; 2) Availability of funds; and 3) Relevance of the proposed project to program priorities.

Match

None required (federal program listing).

This program on SAM.gov

About the federal program

Cancer Control, also called “Cancer Control Grants”
Program number 93.399 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Project grant

How applications are judged

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives.

Match

None required (federal program listing).

This program on SAM.gov

Something wrong on this page? Tell us
What's wrong?